In this study, we demonstrate that SIRT4 activity dampens breast cancer stemness by modulating SIRT1 expression, as supported by the evidence that genetic and pharmacological inhibition of SIRT1 expression or activity could successfully eradicate the expansion of BTICs or xenograft formation induced by SIRT4 loss. Here, SIRT4 is linked to breast carcinoma.